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Abstract 
Aim of the study: To assess the level of acidic mammalian chitinase (AMCase) expression and IL-8 
in nasal inferior turbinate mucosa in patients with mild and moderate to severe allergic rhinitis (AR). 
Material and methods: Participants in this case-control study were divided into three groups, in-
cluding patients with moderate and severe persistent allergic rhinitis, cases with mild forms of persistent 
AR, and control or healthy group. We obtained biopsies of nasal inferior turbinate mucosa from all 
participants. Expression of AMCase and IL-8 mRNAs were evaluated by real-time polymerase chain 
reaction (PCR). The serum levels of AMCase and IL-8 were determined by ELISA. The number of eosin-
ophils per field, blood eosinophils, total serum IgE levels, and specific serum IgE levels were measured. 
Patients’ clinical manifestations were assessed by total nasal syndrome score (TNSS). 
Results: Expression of AMCase and IL-8 in patients with moderate and severe perineal allergic 
rhinitis were significantly elevated compared to the control group and patients with mild persistent 
allergic rhinitis. Serum levels of AMCase and IL-8 were associated with specific IgE, nasal eosinophil 
count, and TNSS. 
Conclusions: According to the results of this study, there might be a relationship between the ex-
pression of AMCase and IL-8 in nasal turbinate mucosa and the severity of allergic rhinitis. 
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Introduction 
Epidemiologic studies indicate that the universal fre-
quency of allergic rhinitis (AR) is growing and affecting 
400 million people [1]. AR is described as “indications of 
sneezing, nasal pruritus, airflow congestion, and mostly 
clear nasal discharge induced by IgE-mediated reactions 
against inhaled allergens”, and includes mucosal swelling 
driven by type 2 helper T (Th2) cells [2]. 
Previously, it was recognized that acidic mammalian 
chitinase (AMCase) is a critical element of IL-13-stimu-
lated reaction in Th2-dominated disorder in both human 
and animal asthma models [3-5]. Furthermore, it was 
thought that chitinase from house dust mite, such as Der-
matophagoides pteronyssinus (D. pteronyssinus) and Der-
matophagoides farinae (D. farinae), present a high poten-
tial of binding to IgE in atopic human sera [6], and are the 
primary allergens for humans and dogs with house dust 
mite hypersensitivity [7]. The production of cytokines and 
chemokines, such as IL-8, which is a member of the CXC 
chemokine family, is heightened by the airway epitheli-
al cells in response to environmental elements, including 
pollens, cigarette smoke, air contaminations, and microor-
ganisms with their secreted extracellular proteins [8-10]. 
IL-8 has been considered a crucial factor in airway inflam-
matory disorder [11, 12]. Moreover, high levels of IL-8 
have been detected in the bronchoalveolar lavage fluid of 
patients with airway swelling disorders [13]. 
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Therefore, the present study was undertaken to: 
Investigate the human serum expression levels of AM-
Case and IL-8 in patients with moderate/severe persistent 
allergic rhinitis (M/S PAR) compared to patients with mild 
persistent allergic rhinitis (M PAR) and the control group. 
Evaluate mRNA expression of AMCase and IL-8 in 
human inferior turbinate mucosa in patients with M/S PAR 
compared to its expression in patients with M PAR and the 
control group. 
Determine the correlation between serum levels of 
AMCase and IL-8 as well as the correlation of each serum 
levels with various pathological parameters. 
Material and methods 
Subjects 
Patients were administered into three groups: M/S 
PAR (n = 30), M PAR (n = 30), and control (n = 30) 
groups. The selected patients presented with no history of 
nasal infection, allergy, smoking, and ongoing drug treat-
ment. During surgery, inferior turbinate mucosal biopsies 
were obtained from all included patients. The diagnosis 
of AR was established on the basis of medical history and 
symptoms (i.e., sneezing, rhinorrhea, and nasal congestion 
occurring most days) lasting for at least 2 years, positive 
skin test results, and positive specific IgE ELISA test for 
house dust mite (Astra Biotech GmbH, Berlin, Germany). 
AR patients were classified as mild or moderate/severe 
persistent according to allergic rhinitis and its impact on 
asthma criteria [14]. Exclusion criteria consisted of current 
smoking status, medical history of asthma and recurrent 
infections of respiratory tract, and the use of anti-allergic 
drugs within 4 weeks prior the study. Before tissue speci-
mens were obtained, all the protocols have been approved 
by the institutional review board at our institution, and all 
participants have signed a written informed consent. Ve-
nous blood samples were obtained from patients. Blood 
drawing, handling, and storage were performed by the 
same researchers. Some of the tissues were immediately 
frozen in liquid nitrogen and stored at –70 centigrade for 
the extraction of RNA, and some samples were paraphined 
for hematoxylin and eosin (H&E) staining. Four-millime-
ter punch nasal biopsies were collected from inferior turbi-
nate of both patients and control groups. Biopsy specimens 
were submerged immediately in 10% buffered formalin 
and prepared for paraffin embedding. Paraffin blocks were 
cut into sections of four microns thick, which were mount-
ed on glass slides. They were prepared for routine H&E 
staining for conventional histopathology (Table 1).
Real-time polymerase chain reaction analysis  
of AMCase and IL-8 
The total RNA was isolated from nasal tissue using 
Biozol reagent (BioFlux, Japan). The quantity and qual-
ity of RNAs were measured by spectrophotometry using 
wavelength absorption ratio (260/280). Some RNA sam-
ples (1 mg/ml) were coupled with DNase1(10 u/ml) for 
30 min to avoid DNA contamination. Following the second 
RNA extraction, cDNA was produced in a 20 ml reaction 
tube from 1 mg total RNA (Thermo Fisher Scientific, Vil-
nius, Lithuania) with a random primer. The reactions were 
incubated at 25°C for 5 min, 42°C for 1 h, and 72°C for 
5 min. The primer sequences, which were used for each 
gene included in the study are shown in Table 1. β-actin 
was used as the internal control. Expressions were deter-
mined by quantitative real-time polymerase chain reaction 
(PCR) using SYBR Green PCR master mix (Takara, Kyo-
to, Japan). A standard curve was established, and efficien-
cy was determined for each set of primers. The determined 
efficiency was typically above 90%. The data were ex-
pressed as fold changes, using comparative cycle threshold 
(ΔΔct method). Relative gene expression was defined by 
the 2-ΔΔct method. 
Assessment of AMCase and IL-8 levels by 
ELISA 
AMCase and IL-8 levels in serum of patients with M/S 
PAR, patients with M PAR, and controls were measured 
using ELISA as per the manufacturer’s protocol (Abnova, 
Taipei, Taiwan). Data were expressed as ng/ml protein. 
Protein concentration was determined with the Starsat 
ELISA reader (Awarness, Phoenix, AZ, USA). 
Statistical analyses 
Statistical analyses were carried out using SPSS for 
Windows (IBM SPSS Statistics, IBM). One-way ANOVA, 
along with post-hoc Tukey’s test was performed in order to 
evaluate whether the values obtained by real-time PCR and 
ELISA differ among the nasal mucosa of healthy controls 
and patients with mild and M/S PAR. Student’s t-test was 
used to analyze the differences in specific IgE between 
M/S PAR and mild PAR. Correlations were assessed with 
Pearson’s correlation test. A value of p < 0.05 was consid-
ered as statistically significant. 
Table 1. Sequences of PCR primers 
β-actin Forward primer: 
5-AGC GAG CAT CCC CCA AAG TT-3 
Reverse primer: 
5-GGG CAC GAA GGC TCA TCA TT-3




IL-8 Forward primer: 
5-TGAAGGACATGGCTTAGAAGTG-3 
Reverse primer: 5-GGTGCAAGGGTCACAGTGTT-3 
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Results 
Clinical characteristics of participants 
The characteristics of patients with persistent allergic 
rhinitis and healthy controls are demonstrated in Table 2. 
As shown in Table 2, age was similarly distributed among 
the healthy controls and the patients with PAR. The du-
ration of disease did not significantly differ between the 
groups of patients with M and M/S PAR, and serum total 
IgE levels were higher in patients with M and M/S PAR 
than in individuals with healthy nasal mucosa. 
Gene expression levels of AMCase and IL-8 in 
nasal mucosa 
The gene expression levels of AMCase and IL-8 were 
determined in healthy, M, and M/S PAR nasal mucosa 
samples using real-time PCR. As shown in Figure 1 and 
Table 3, the expression levels of AMCase and IL-8 pre-
sented significant increase in nasal mucosa of patients with 
M/S PAR compared to nasal mucosa of patients with M 
PAR and the controls. Similarly, the gene expressions of 
AMCase and IL-8 were statistically different between M 
PAR and control groups. 
Table 2. Demographic characteristics of participants 
Variable Healthy control M PAR M/S PAR
Gender, male/female 18/12 20/10 22/8
Age 28.5 ±6.42 26.03 ±4.03 26.7 ±4.87
SIgE for house dust mite (IU/ml) 0 0.51 ±0.15 4.57 ±5.56
TIgE (IU/ml) 82.63 ±43.88 236.3 ±33.24 1061.1 ±88.41
Blood eosinophil counts 74.5 ±40.02 255.7 ±70.96 607.27 ±117.37
Degree of eosinophil infiltration into nasal mucosa 0.5 ±0.5 1.7 ±0.59 3.63 ±1.88
Disease duration in years 0 15.63 ±2.09 17.17 ±4.39
Fig. 1. Real-time PCR analysis of AMCase (A) and IL-8 (B). mRNA in inferior turbinate nasal mucosal tissue from 
controls and patients with M PAR and M/S PAR. * indicates significant difference in the expression levels of AMCase 
and IL-8 among normal, mild, and moderate/severe persistent allergic nasal mucosa (p < 0.05). Results are shown as 
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Table 3. Comparison of baseline characteristics, AMCase 
gene expression, IL-8 gene expression, serum levels of 
AMCase, and IL-8 among control group, patients with M 
PAR, and patients with M/S PAR 
Variable Control M PAR M/S PAR
AMCase gene expression 1.4 ±1.15 2.81 ±1.2 4.13 ±3.32
IL-8 gene expression 1.01 ±0.53 2.25 ±0.95 4.04 ±3.06
Serum AMCase level 17.89 ±2.98 19.97 ±3.65 23.79 ±2.78
Serum IL-8 level 10.1 ±3.21 14.41 ±2.22 26.08 ±3.35
Results are shown as mean ±SD
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Fig. 2. Comparison between serum levels of AMCase (A) and IL-8 (B) in controls and patients with M PAR and M/S 
PAR. * indicates a significant difference in the expression levels of AMCase and IL-8 among normal, M PAR, and M/S 
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Serum levels of AMCase and IL-8 in patients 
with M/S PAR, M PAR, and healthy controls 
As shown in Figure 2 and Table 3, AMCase and IL-8 
levels (ng/ml) were measured in the serum obtained from 
patients with M/S PAR, M PAR, and healthy controls. Sig-
nificantly higher levels of AMCase and IL-8 were found in 
serum obtained from patients with M/S PAR compared to 
healthy participants (p < 0.05) and patients with M PAR. 
Likewise, the differences between the patients with M 
PAR and healthy controls in terms of levels of AMCase 
and IL-8 were statistically significant (p < 0.05). 
Associations between serum levels of AMCase 
with immunopathogenesis of M/S PAR 
As shown in Figure 3, there were considerable associa-
tions between serum AMCase levels and TNSS (R = 0.576, 
p < 0.05; Fig. 3A), degree of eosinophil infiltration to na-
sal (R = 0.393, p < 0.05; Fig. 3B), and SIgE (R = 0.524, 
p < 0.05; Fig. 3C). On the other hand, serum AMCase 
levels did not correlate with blood eosinophil counts 
(R = 0.178, p > 0.05; Fig. 3D) or TIgE (R = 0.277, 
p > 0.05; Fig. 3E). Moreover, the correlation between se-
rum AMCase levels and serum IL-8 levels was statistically 
significant (R = 0.525, p < 0.05; Fig. 3F). 
Associations between serum levels of IL-8 with 
immunopathogenesis of M/S PAR 
As shown in Figure 4, the correlations between 
serum IL-8 levels and TNSS (R = 0.428, p < 0.05; 
Fig. 4A), degree of eosinophil infiltration to nasal (R = 0.547, 
p < 0.05; Fig. 4B), and SIgE (R = 0.473, p < 0.05; Fig. 4C) 
were statistically visible. In contrast, there was no asso-
ciation between serum IL-8 levels with blood eosinophil 
counts (R = 0.114, p > 0.05; Fig. 4D) and TIgE (R = 0.267, 
p > 0.05; Fig. 4E). 
Discussion 
In this study, gene expressions of AMCase and IL-8 
in the human nasal mucosa of inferior turbinate as well 
as the serum levels were investigated. Although local and 
serum production of AMCase and IL-8 in AR have pre-
viously been reported [15-18], this was the first study (as 
far as the authors of the present study are concerned) con-
ducted on the correlation among AMCase and IL-8 with 
disease parameters, including disease severity and clinical 
characteristics. The findings of the present study showed 
that there was an observable increase in serum levels and 
gene expression of AMCase and IL-8 in patients with M/S 
PAR compared to patients with M PAR and the controls. 
Similar to the data presented here, Cho et al. [15] reported 
that production of AMCase increased in patients with AR 
compared to healthy controls. Moreover, Gosset et al. [19] 
stated that production of IL-8 in patients with AR raised 
compared to healthy controls. On the contrary, the results 
obtained from the present study was rejected by Dasson-
ville [20] and Dasilva [21]. Data on cellular spreading is 
required to disclose practical characteristics of AMCase. 
The gene expression of AMCase has been recognized by 
northern blotting analysis in human submandibular gland 
and stomach [22]. This pattern of spreading suggested that 
AMCase takes on a significant role in the digestion of in-
gested chitin-coated animals and plants rather than being 
a mere defense system [22]. Nevertheless, it is possible 
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Fig. 3. Correlations between serum levels of AMCase and total nasal score syndrome (TNSS) (A), nasal eosinophil count 
(B), specific IgE (SIgE) (C), blood eosinophil count (D), total IgE (TIgE) (E), and serum IL-8 levels (F) in patients with 
moderate/severe persistent allergic rhinitis (M/S PAR)
that AMCase participates in defense against chitin coating 
pathogens, such as fungi. Overdijk et al. [23] suggested 
that the attendance of chitinase in human serum may be 
due to a function of AMCase in the defense against chitin-
ous pathogens, such as fungi. This suggestion is supported 
by the observation that a systemic infection with Asper-
gillus Fumigates results in increasing chitinase levels and 
this, in turn, can be inhibited by antifungal treatment [24]. 
However, a great number of macromolecules, consisting of 
mucine and antibacterial substances, are secreted by sub-
mucosal glands and epithelial cells in nasal mucosa. Cho 
et al. [15] reported that AMCase was noticeably produced 
in the epithelial cells and submucosal glands in healthy 
nasal mucosa, indicating its participation in defense against 
chitin-containing pathogens. Moreover, it may play a role 
in allergic reaction similar to other inflammatory media-
tors in allergic rhinitis, due to its up-regulation of allergic 
conditions. One of the strengths of this study was that the 
correlations among AMCase and IL-8 with clinical char-
acteristics were analyzed. It was found that serum levels 
of AMCase and IL-8 were positively associated with SIgE 
and the number of infiltrating eosinophils to nasal muco-
sa. Nasal eosinophils could induce inflammation, which 
cause nasal hyperactivity. Interestingly, there were visible 
correlations between AMCase and IL-8 with TNSS; there-
fore, the present data support the concept that AMCase and 
IL-8 are associated with disease severity. Serum levels of 
AMCase are associated with congestion and sneezing. In 
the present study, there was a correlation between IL-8 and 
sneezing; however, the correlations between both AMCase 
and IL-8 with rhinorrhea were not statistically significant. 
In addition, there was a positive correlation between serum 
levels of AMCase and IL-8, indicating that up-regulation 
of AMCase was associated with up-regulation of IL-8. An-
other noteworthy finding was that serum levels of AMCase 
and IL-8 were not correlated with blood eosinophil count, 
suggesting that it was more reasonable to estimate the level 
of eosinophils in tissue than in blood. 
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Fig. 4. Correlations between serum levels of IL-8 and total 
nasal score syndrome (TNSS) (A), nasal eosinophil count 
(B), specific IgE (SIgE) (C), blood eosinophil count (D), 
and total IgE (TIgE) (E) in patients with moderate/severe 
persistent allergic rhinitis (M/S PAR)
Conclusions 
The present study showed that disease parameters are 
associated with up-regulation of AMCase and IL-8. 
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